F
Fernando Fuertes
Researcher at University of Zaragoza
Publications - 6
Citations - 2082
Fernando Fuertes is an academic researcher from University of Zaragoza. The author has contributed to research in topics: Prostate cancer & Cancer. The author has an hindex of 6, co-authored 6 publications receiving 2009 citations.
Papers
More filters
Journal ArticleDOI
Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes
Julius Gudmundsson,Patrick Sulem,Valgerdur Steinthorsdottir,Jon Thor Bergthorsson,Gudmar Thorleifsson,Andrei Manolescu,Thorunn Rafnar,Daniel F. Gudbjartsson,Bjarni A. Agnarsson,Adam Baker,Asgeir Sigurdsson,Kristrun R. Benediktsdottir,Margret Jakobsdottir,Thorarinn Blondal,Simon N. Stacey,Agnar Helgason,Steinunn Gunnarsdottir,Adalheidur Olafsdottir,Kari T. Kristinsson,Birgitta Birgisdottir,Shyamali Ghosh,Steinunn Thorlacius,Dana Magnusdottir,Gerdur Stefansdottir,Kristleifur Kristjansson,Yu Z. Bagger,Robert L. Wilensky,Muredach P. Reilly,Andrew D. Morris,Charlotte H. Kimber,Adebowale Adeyemo,Yuanxiu Chen,Jie Zhou,Wing-Yee So,Peter C.Y. Tong,Maggie C.Y. Ng,Torben Hansen,Gitte Andersen,Knut Borch-Johnsen,Knut Borch-Johnsen,Knut Borch-Johnsen,Torben Jørgensen,Alejandro Tres,Fernando Fuertes,M. Ruiz-Echarri,Laura Asín,Berta Saez,Erica Van Boven,Siem M. Klaver,Dorine W. Swinkels,Katja K.H. Aben,Theresa Graif,John Cashy,Brian K. Suarez,Onco Van Vierssen Trip,Michael L. Frigge,Carole Ober,Marten H. Hofker,Marten H. Hofker,Cisca Wijmenga,Cisca Wijmenga,Claus Christiansen,Daniel J. Rader,Colin N. A. Palmer,Charles N. Rotimi,Juliana C.N. Chan,Oluf Pedersen,Oluf Pedersen,Gunnar Sigurdsson,Rafn Benediktsson,Eirikur Jonsson,Gudmundur V. Einarsson,Jose I. Mayordomo,William J. Catalona,Lambertus A. Kiemeney,Rosa B. Barkardottir,Jeffrey R. Gulcher,Unnur Thorsteinsdottir,Augustine Kong,Kari Stefansson +79 more
TL;DR: Results from eight case-control groups demonstrate that this variant in TCF2 (HNF1β), a gene known to be mutated in individuals with maturity-onset diabetes of the young type 5, confers protection against type 2 diabetes.
Journal ArticleDOI
Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer
Julius Gudmundsson,Patrick Sulem,Thorunn Rafnar,Jon Thor Bergthorsson,Andrei Manolescu,Daniel F. Gudbjartsson,Bjarni A. Agnarsson,Asgeir Sigurdsson,Kristrun R. Benediktsdottir,Thorarinn Blondal,Margret Jakobsdottir,Simon N. Stacey,Jelena Kostic,Kari T. Kristinsson,Birgitta Birgisdottir,Shyamali Ghosh,Droplaug N Magnusdottir,Steinunn Thorlacius,Gudmar Thorleifsson,S. Lilly Zheng,Jielin Sun,Bao Li Chang,J. Bradford Elmore,Joan P. Breyer,Kate M. McReynolds,Kevin M. Bradley,Brian L. Yaspan,Fredrik Wiklund,Pär Stattin,Sara Lindström,Hans-Olov Adami,Hans-Olov Adami,Shannon K. McDonnell,Daniel J. Schaid,Julie M. Cunningham,Liang Wang,James R. Cerhan,Jennifer L. St. Sauver,Sara D. Isaacs,Kathleen E. Wiley,Alan W. Partin,Patrick C. Walsh,Sonia Polo,M. Ruiz-Echarri,Sebastian Navarrete,Fernando Fuertes,Berta Saez,Javier Godino,Philip C. Weijerman,Dorine W. Swinkels,Katja K.H. Aben,J. Alfred Witjes,Brian K. Suarez,Brian T. Helfand,Michael L. Frigge,Kristleifur Kristjansson,Carole Ober,Eirikur Jonsson,Gudmundur V. Einarsson,Jianfeng Xu,Henrik Grönberg,Jeffrey R. Smith,Jeffrey R. Smith,Stephen N. Thibodeau,William B. Isaacs,William J. Catalona,Jose I. Mayordomo,Lambertus A. Kiemeney,Rosa B. Barkardottir,Jeffrey R. Gulcher,Unnur Thorsteinsdottir,Augustine Kong,Kari Stefansson +72 more
TL;DR: The 2p15 variant shows a significantly stronger association with more aggressive, rather than less aggressive, forms of the disease.
Journal ArticleDOI
Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility
Julius Gudmundsson,Patrick Sulem,Daniel F. Gudbjartsson,Thorarinn Blondal,Arnaldur Gylfason,Bjarni A. Agnarsson,Kristrun R. Benediktsdottir,Droplaug N Magnusdottir,Gudbjorg Orlygsdottir,Margret Jakobsdottir,Simon N. Stacey,Asgeir Sigurdsson,Tiina Wahlfors,Teuvo L.J. Tammela,Joan P. Breyer,Kate M. McReynolds,Kevin M. Bradley,Berta Saez,Javier Godino,Sebastian Navarrete,Fernando Fuertes,L. Murillo,E. Polo,Katja K.H. Aben,Inge M. van Oort,Brian K. Suarez,Brian T. Helfand,Donghui Kan,Carlo Zanon,Carlo Zanon,Michael L. Frigge,Kristleifur Kristjansson,Jeffrey R. Gulcher,Gudmundur V. Einarsson,Eirikur Jonsson,William J. Catalona,Jose I. Mayordomo,Lambertus A. Kiemeney,Jeffrey R. Smith,Jeffrey R. Smith,Johanna Schleutker,Rosa B. Barkardottir,Augustine Kong,Unnur Thorsteinsdottir,Unnur Thorsteinsdottir,Thorunn Rafnar,Kari Stefansson,Kari Stefansson +47 more
TL;DR: In a multivariate analysis using 22 prostate cancer risk variants typed in the Icelandic population, it is estimated that carriers in the top 1.3% of the risk distribution are at a 2.5 times greater risk of developing the disease than members of the general population.
Journal ArticleDOI
A germline variant in the TP53 polyadenylation signal confers cancer susceptibility
Simon N. Stacey,Patrick Sulem,Aslaug Jonasdottir,Gisli Masson,Julius Gudmundsson,Daniel F. Gudbjartsson,Olafur T. Magnusson,Sigurjon A. Gudjonsson,Bardur Sigurgeirsson,Kristin Thorisdottir,Rafn Ragnarsson,Kristrun R. Benediktsdottir,Bjørn A. Nexø,Anne Tjønneland,Kim Overvad,Peter Rudnai,Eugene Gurzau,Kvetoslava Koppova,Kari Hemminki,Cristina Corredera,Victoria Fuentelsaz,Pilar Royo Grasa,Sebastian Navarrete,Fernando Fuertes,Maria D. Garcia-Prats,Enrique Sanambrosio,Angeles Panadero,Ana de Juan,Almudena Garcia,Fernando Rivera,Dolores Planelles,Virtudes Soriano,Celia Requena,Katja K.H. Aben,Michelle M. van Rossum,Ruben Cremers,Inge M. van Oort,Dick Johan Van Spronsen,Jack A. Schalken,Wilbert H.M. Peters,Brian T. Helfand,Jenny L Donovan,Freddie C. Hamdy,Daniel Badescu,Ovidiu Codreanu,Mariana Jinga,Irma Eva Csiki,Vali Constantinescu,Paula Badea,Ioan Nicolae Mates,Daniela E. Dinu,Adrian Constantin,Dana Mates,Sjofn Kristjansdottir,Bjarni A. Agnarsson,Eirikur Jonsson,Rosa B. Barkardottir,Gudmundur V. Einarsson,Fridbjorn Sigurdsson,Páll Helgi Möller,Tryggvi Stefansson,Trausti Valdimarsson,Oskar T. Johannsson,Helgi Sigurdsson,Thorvaldur Jonsson,Jon G. Jonasson,Laufey Tryggvadottir,Terri Rice,Helen M. Hansen,Yuanyuan Xiao,Daniel H. Lachance,Brian P. O'Neill,Matthew L. Kosel,Paul A. Decker,Gudmar Thorleifsson,Hrefna Johannsdottir,Hafdis T. Helgadottir,Asgeir Sigurdsson,Valgerdur Steinthorsdottir,Annika Lindblom,Robert S. Sandler,Temitope O. Keku,Karina Banasik,Torben Jørgensen,Daniel R. Witte,Torben Hansen,Torben Hansen,Torben Hansen,Oluf Pedersen,Oluf Pedersen,Oluf Pedersen,Viorel Jinga,David E. Neal,William J. Catalona,Margaret Wrensch,John K. Wiencke,Robert B. Jenkins,Eduardo Nagore,Ulla Vogel,Lambertus A. Kiemeney,Rajesh Kumar,Jose I. Mayordomo,Jón Ólafsson,Augustine Kong,Unnur Thorsteinsdottir,Unnur Thorsteinsdottir,Thorunn Rafnar,Kari Stefansson,Kari Stefansson +108 more
TL;DR: A genome-wide association study of 16 million SNPs identified through whole-genome sequencing of 457 Icelanders found that rs78378222 is in the 3′ untranslated region of TP53 and changes the AATAAA polyadenylation signal to AATACA, resulting in impaired 3′-end processing of TP 53 mRNA.
Journal ArticleDOI
A study based on whole-genome sequencing yields a rare variant at 8q24 associated with prostate cancer.
Julius Gudmundsson,Patrick Sulem,Daniel F. Gudbjartsson,Gisli Masson,Bjarni A. Agnarsson,Kristrun R. Benediktsdottir,Asgeir Sigurdsson,Olafur T. Magnusson,Sigurjon A. Gudjonsson,Droplaug N Magnusdottir,Hrefna Johannsdottir,Hafdis T. Helgadottir,Simon N. Stacey,Adalbjorg Jonasdottir,Stefania B. Olafsdottir,Gudmar Thorleifsson,Jon G. Jonasson,Laufey Tryggvadottir,Sebastian Navarrete,Fernando Fuertes,Brian T. Helfand,Qiaoyan Hu,Irma Eva Csiki,Ioan Nicolae Mates,Viorel Jinga,Katja K.H. Aben,Inge M. van Oort,Sita H. Vermeulen,Jenny L Donovan,Freddy C. Hamdy,Chi-Fai Ng,Peter K. F. Chiu,Kin-Mang Lau,Maggie C.Y. Ng,Jeffrey R. Gulcher,Augustine Kong,William J. Catalona,Jose I. Mayordomo,Gudmundur V. Einarsson,Rosa B. Barkardottir,Eirikur Jonsson,Dana Mates,David E. Neal,Lambertus A. Kiemeney,Unnur Thorsteinsdottir,Unnur Thorsteinsdottir,Thorunn Rafnar,Kari Stefansson,Kari Stefansson +48 more
TL;DR: A new low-frequency variant at 8q24 associated with prostate cancer in European populations, rs188140481[A] is identified and its association remains significant after adjustment for all known risk-associated variants.